Despite ongoing challenges, health system leaders across Australia, Canada, Germany, the Netherlands, and the United Kingdom are generally optimistic about their organizations and the sector as a whole, according to Deloitte Global’s 2026 Health Care Outlook Survey. More than 80% of executives surveyed in those countries reported a “positive” or “cautiously positive” outlook for their own organizations, with 1% expressing a negative view. When asked about the health care industry overall, 72% said they were upbeat about the year ahead, again with 1% having a negative view.
By contrast, US health system leaders are notably more cautious, partly due to ongoing uncertainties regarding tariffs, drug pricing, and regulatory changes. The current environment may have contributed to 20% of US respondents expressing a negative industry outlook for 2026 and 33% feeling uncertain—a notable increase from the 3% who expressed uncertainty a year ago.
To capture leaders’ perspectives and plans, Deloitte Global, in collaboration with the Deloitte US Center for Health Solutions, conducted its annual global outlook survey of 180 C-suite executives from large health systems in August and September 2025. Survey respondents were based in Australia, Canada, Germany, the Netherlands, the United Kingdom, and the United States. These nations represent significant portions of the global economy and the health care sector; however, the insights primarily reflect the perspectives of developed health care markets. Anecdotally, developing markets may face similar priorities, though this was not quantitatively verified.
Health system leaders across all six countries agreed that their 2026 strategies will likely be strongly influenced by:
While generative artificial intelligence and agentic AI could support progress on these fronts, most health system executives do not expect a major strategic impact from AI in 2026. Currently, about 30% of surveyed health systems report operating gen AI at scale in select areas of their organizations—across both the United States and other surveyed countries—while just 2% have deployed AI across their entire enterprise. This limited use reflects the early stage of adoption, particularly on the clinical side.
About 70% of non-US health system executives expect operating revenue and margins to increase next year, while over 50% predict that operating costs will be flat or decline slightly. Only 13% of respondents said they expect operating costs to increase “significantly” next year. To boost operating revenue, survey respondents said they intend to invest in core business technologies, expand the use of digital and AI tools and services, and improve workforce engagement and retention.
When asked where they expect savings to come from in 2026, 64% of respondents said AI could reduce costs by standardizing and automating workflows. More than half (55%) also see savings potential from the increased use of predictive analytics to optimize the workforce, while 49% expect benefits from tech-enabled patient engagement and remote monitoring. In addition, care model transformation is expected to contribute to revenue growth next year, particularly through expanding outpatient services, increasing digital offerings, and deploying AI agents to follow up with patients. AI can also be used for risk stratification by evaluating health risks based on genetics, environment, and lifestyle, which can lead to more proactive and targeted interventions.
An increased focus on preventive care was cited as a priority by many non-US executives. Nearly half of those respondents (45%) said care model transformation would be a leading trend in 2026, and 38% said their organizations would focus on preventive care and early detection in the year ahead. Specific interventions include regular health checks and disease screening, immunizations, and providing advice and guidance to encourage healthy living. By contrast, only 7% of US health system executives expect preventive care to be a major trend for their organizations in 2026. Most US health systems receive a substantial portion of their revenue through private insurance fee-for-service payments, whereas many health systems around the world are primarily government-funded. The fee-for-service model incentivizes volume over value, emphasizing treatment over prevention.1 In single-payer systems, financial incentives are generally aligned with keeping people healthy and minimizing costly interventions.2
Attracting and retaining clinical staff is a challenge for hospitals around the world as populations age and fewer professionals enter the workforce. The World Health Organization projects a shortage of 4.5 million nurses by 2030.3 In the United Kingdom, for example, 40% of general practitioners expect to leave the profession within the next five years.4 The loss of experienced clinicians could have profound implications for patient care, staff morale, and job satisfaction.5
It’s not surprising that health system executives cited workforce challenges as their top concern for 2026, and more than 90% said improving productivity would be a priority. In the year ahead, respondents said they intend to invest in workforce retention and engagement and rely more on AI and other tools to help improve productivity.
Health care organizations often handle highly sensitive protected health information, which is vital for patient safety. It is also a valuable target for cybercriminals. Cyberattacks targeting hospitals have become more frequent, sophisticated, and costly, with ransomware and supply chain attacks emerging as major threats to health systems around the world.8 Nearly half of non-US health executives (48%) cited cybersecurity and data privacy as a top concern for 2026. They expect that about 14% of their technology budgets will go toward cyber tools and enhanced cyber processes in 2026. That puts cyber investments on par with funds earmarked for gen AI and digital health or consumer engagement platforms, and well ahead of expected investments in cloud computing. Cybersecurity is expected to be slightly less of a priority for US health systems, where 35% of executives said it was a top concern and anticipate spending about 10% of their technology budgets on it.
Globally, cybercriminals are leveraging AI to help maximize financial gain and disruption, with ransomware attacks on hospitals and health systems increasing worldwide.9 When malware encrypts hospital systems and records, it can disrupt patient care. These disruptions not only increase the risk of medical errors and threaten patient safety but can also result in significant financial damage. Beyond the financial impact, such incidents can harm an organization’s reputation and erode the trust of patients and communities.
The growing threat of cyberattacks has prompted action in regions around the world. The European Commission’s EU Cybersecurity Reserve—a pool of cybersecurity specialists and services ready to respond to large-scale cyber incidents—is set to take effect in 2026.10 In Canada, the Centre for Cyber Security is strengthening health care defenses through training, security drills, and enhanced education.11 In the United States, the HIPAA Security Rule requires hospitals to implement comprehensive safeguards to protect patient data,12 but some states have introduced more rigorous regulations.13
The transformative potential of gen AI and agentic AI is widely recognized among health system leaders. However, just 22% of non-US respondents said AI was likely to be a major focus at their facilities in 2026, compared with 37% of US health system executives. Still, there is broad agreement that AI technology could help improve operational efficiencies, streamline administrative tasks, and provide decision support to clinicians. Globally, the AI in health care market is projected to grow from $39 billion in 2025 to $504 billion by 2032. North America currently dominates in the use of AI in health care, accounting for 49% of the global market share in 2024.14
Regulatory uncertainty around the use of AI in health settings has likely delayed adoption in many regions. The EU AI Act, in effect since August 2024, requires nearly all AI-enabled medical devices, diagnostic algorithms, and decision-support tools to undergo mandatory risk management review.15 Canada’s proposed Artificial Intelligence and Data Act, introduced in 2022, failed to progress in Parliament in early 2025. In the absence of an AI-specific law, provinces and their health systems continue to rely on existing privacy laws to guide AI use. Australia has not yet implemented statutes governing the use of AI but is developing a framework and mandatory guardrails for high-risk applications.16
In addition to some regulatory uncertainty, health systems are under increasing pressure to demonstrate a clear return on investment for their AI initiatives. Slightly more than half of respondents (51%) said they either haven’t measured returns or determined that it is too soon to see results. However, 31% of respondents reported “moderate” financial returns and 3% said the ROI has been “significant.” In the year ahead, surveyed executives expect gen AI and agentic AI to account for 19% of their technology budgets.
As health systems around the world prepare for 2026, executives appear cautiously optimistic, focusing on growth and transformation even as they face persistent challenges with margins, workforce shortages, cybersecurity threats, and regulatory uncertainty. At the same time, care is increasingly shifting from hospitals to the home and community through virtual care, and remote monitoring. Care is also moving from reactive to proactive and preventive. The challenge for health systems is not simply to adopt new technologies, but to align them with sustainable business models, empowered workforces, and whole-health outcomes that deliver lasting value for patients.